MicroRNA-877-5p promotes osteoblast differentiation by targeting EIF4G2 expression

Area of Science:

• Biomedical research
• Molecular biology
• Orthopedics

Background:

• Osteoblasts are crucial for bone remodeling and treating orthopedic diseases.
• The role of microRNA-877-5p (miR-877-5p) in osteoblast differentiation remains unclear, despite its known function in osteoarthritis chondrocytes.

Purpose of the Study:

• To investigate the effect of miR-877-5p on osteoblast differentiation and bone formation.
• To identify the molecular targets of miR-877-5p involved in this process.

Main Methods:

• Real-time RT-PCR to quantify miR-877-5p expression during osteogenic differentiation of MC3T3-E1 cells.
• Assays for osteoblast markers (ALP, collagen type I a1, osteopontin), alizarin red staining, and ALP staining.
• Bioinformatic prediction and dual-luciferase reporter gene assay to identify and verify miR-877-5p targets, specifically EIF4G2.

Main Results:

• miR-877-5p expression was upregulated during osteogenic differentiation.
• Overexpression of miR-877-5p enhanced osteogenic differentiation, evidenced by increased mineralization, ALP activity, and gene expression.
• Knockdown of miR-877-5p inhibited these processes.
• miR-877-5p was confirmed to directly target eukaryotic translation initiation factor 4γ2 (EIF4G2).
• EIF4G2 overexpression counteracted the pro-osteogenic effects of miR-877-5p.

Conclusions:

• miR-877-5p promotes osteoblast differentiation and bone formation.
• The mechanism involves direct targeting of EIF4G2.
• miR-877-5p represents a potential therapeutic target for bone formation-related disorders.